Tag: Cardiol Therapeutics Inc.

June 10, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...
June 3, 2019

Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD

Cardiol Therapeutics Inc. (TSX:CRDL, OTCQX:CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical cannabidiol (CBD)...
May 30, 2019

Cardiol Therapeutics Commences Trading on the OTCQX

Cardiol Therapeutics Inc. (TSX:CRDL) (OTCQX: CRTPF) ("Cardiol" or the "Company"), a leader in the research and commercial development of pharmaceutical...
April 30, 2019

Cardiol is a Leader in Pharmaceutically Pure CBD

Cardiol Therapeutics Inc. (TSX:CRDL,OTC:CRTPF) was featured in an article by Technical420 which covered the shift away from cannabis cultivation into a...
March 28, 2019

Biotech Companies Benefiting From Legal Cannabis Research and Development

As the legal cannabis market continues to expand into new jurisdictions across the globe, companies are beginning to take advantage...
March 28, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A

Cardiol Therapeutics Inc. (TSX:CRDL) ("Cardiol" or the "Company"), a leader in the research and development of pharmaceutical cannabidiol and targeted...
March 21, 2019

Cardiol Therapeutics Releases Video on Pharmaceutical CBD Market

Cardiol Therapeutics Inc. (TSX:CRDL) (OTC:CRTPF) has released a video regarding the progress it has made in development of its pharmaceutical-grade CBD...